dpp4 vs sglt2 vs glp-1 Comparison of receptor agonists and DPP-4 inhibitors DPP-4 inhibitors and GLP-1RAs: cardiovascular

10.1001/jamainternmed.2024.4369 Summary Keywords cardiovascular disease, cardiovascular outcome, glucagon-like peptide-1 receptor agonists, heart failure, obesity Citation Turkistani Y (2025) Glucagon-like peptide-1 receptor agonists: a review from a cardiovascular perspective

Autophagy 17:42664285

It also lists TRIUMPH-2 for retatrutide in adults with type 2 diabetes and obesity or overweight

These effects were more pronounced in patients with baseline eGFR below 60 mL/min/1.73 m 2

Its role is to make objective health information more accessible so patients can better understand and participate in their care

That can stress an already weak heart